TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 1 filers reported holding TRINITY BIOTECH INVT LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $35,398,000 | -8.2% | 43,000,000 | -10.4% | 1.24% | -7.0% |
| Q1 2018 | $38,550,000 | -2.4% | 48,000,000 | 0.0% | 1.34% | -14.0% |
| Q4 2017 | $39,492,000 | +3.4% | 48,000,000 | 0.0% | 1.55% | -9.7% |
| Q3 2017 | $38,190,000 | -0.6% | 48,000,000 | 0.0% | 1.72% | -16.1% |
| Q2 2017 | $38,430,000 | -1.3% | 48,000,000 | 0.0% | 2.05% | +36.6% |
| Q1 2017 | $38,917,000 | -3.7% | 48,000,000 | 0.0% | 1.50% | -9.7% |
| Q4 2016 | $40,401,000 | -13.6% | 48,000,000 | 0.0% | 1.66% | -23.6% |
| Q3 2016 | $46,775,000 | +6.5% | 48,000,000 | 0.0% | 2.18% | +25.9% |
| Q2 2016 | $43,935,000 | – | 48,000,000 | – | 1.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |